Issue 27 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Northwell Health reopens cancer services after COVID-19 deluge

NCI BSA approves nine new and reissue concepts

(Social + geographic) distance = Ongoing challenges in disparities for rural cancer patients

In Brief

Yale Cancer Center receives $2.8M NCI cancer systems immunology grant

USC Norris receives $5 million for cancer drug discoveries

Alexander Drilon named chief of the Early Drug Development Service at MSK

Nancy R. Daly named CEO of Conquer Cancer, the American Society of Clinical Oncology Foundation

ASCO's Association for Clinical Oncology establishes PAC

Florida Cancer Specialists & Research Institute breaks ground for new location

Clinical Roundup

NCCN Guidelines for patients can help patients recognize side-effects of immunotherapy

Drugs & Targets

Phesgo receives FDA approval in breast cancer indication for at home treatment

Keytruda receives FDA approval as first-line immunotherapy for MSI-H/dMMR MCC

Bavencio receives FDA approval for urothelial carcinoma maintenance treatment

Reblozyl approved by European Commission for transfusion-dependent anemia in adults with MDS or beta thalassemia

Guardant Health launches real-world clinical-genomic platform to accelerate precision oncology drug development

NCI Trials

NCI Trials for July 2020

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login